Legal Representation
Attorney
Mary M. Cheli
USPTO Deadlines
Application History
9 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 3, 2011 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Jan 3, 2011 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
Oct 20, 2010 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
May 28, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 28, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 28, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
May 28, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 16, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 13, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; all in International Class 5
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005